Page last updated: 2024-08-23

4,4'-diisothiocyanostilbene-2,2'-disulfonic acid and B-Cell Chronic Lymphocytic Leukemia

4,4'-diisothiocyanostilbene-2,2'-disulfonic acid has been researched along with B-Cell Chronic Lymphocytic Leukemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Branca, JA; Chow, KH; Costa, M; Hasham, MG; Labrie, NJ; Mills, KD; Perkins, BRA; Roopenian, DC; Rosales, C; Sproule, TJ; Stafford, G; Wilson, JJ; Wolf, EE1
Branca, J; Breggia, A; Cavallo, F; Chase, B; Chavaree, M; Donghia, NM; Emery, I; Hasham, MG; Hedlund, J; Jasin, M; Lamont, KR; Mills, KD; Rüter, J1
Campàs, C; Coll-Mulet, L; Cosialls, AM; de Frias, M; Domingo, A; Gil, J; González-Gironès, DM; Iglesias-Serret, D; Pons, G; Santidrián, AF1

Other Studies

3 other study(ies) available for 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Enhancing the efficacy of glycolytic blockade in cancer cells
    Cancer biology & therapy, 2019, Volume: 20, Issue:2

    Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Deoxyglucose; Drug Synergism; Female; Glycolysis; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Neoplasms; Rad51 Recombinase; Xenograft Model Antitumor Assays

2019
Attenuating homologous recombination stimulates an AID-induced antileukemic effect.
    The Journal of experimental medicine, 2013, May-06, Volume: 210, Issue:5

    Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Active Transport, Cell Nucleus; Animals; B-Lymphocytes; Cell Death; Cell Line, Transformed; Cell Line, Tumor; Cell Nucleus; Cytidine Deaminase; DNA Breaks, Double-Stranded; DNA Repair; Gene Expression Regulation, Leukemic; Histones; Homologous Recombination; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mice; Rad51 Recombinase; Radiation, Ionizing

2013
The potential anticancer agent PK11195 induces apoptosis irrespective of p53 and ATM status in chronic lymphocytic leukemia cells.
    Haematologica, 2007, Volume: 92, Issue:12

    Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Apoptosis; Ataxia Telangiectasia Mutated Proteins; B-Lymphocytes; Benzodiazepinones; Caspase Inhibitors; Caspases; Cell Cycle Proteins; Cytochromes c; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Enzyme Activation; Female; Humans; Hypolipidemic Agents; Indoleacetic Acids; Isoquinolines; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Membrane Potential, Mitochondrial; Middle Aged; Mitochondria; Protein Serine-Threonine Kinases; Receptors, GABA; T-Lymphocytes; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Voltage-Dependent Anion Channels

2007